Tissue‐type plasminogen activator and C‐reactive protein in acute coronary heart disease. A nested case–control study
- 1 February 2000
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 247 (2) , 205-212
- https://doi.org/10.1046/j.1365-2796.2000.00604.x
Abstract
Gram J, Bladbjerg E‐M, Møller L, Sjøl A, Jespersen J (Department of Clinical Biochemistry, Ribe County Hospital and the Institute for Thrombosis Research, South Jutland University Centre, E...Keywords
This publication has 17 references indexed in Scilit:
- Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina PectorisCirculation, 1996
- Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control StudyAmerican Journal of Epidemiology, 1996
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.Circulation, 1993
- Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery diseaseEuropean Heart Journal, 1989
- On the Usefulness of Fibrinolysis Variables in the Characterization of a Risk Group for Myocardial ReinfarctionActa Medica Scandinavica, 1987
- THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSISThe Lancet, 1956